Reaction

Vascular Compression reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 307 reports · 13 co-occurring drugs

As of the last recalculation, Vascular Compression appears in 307 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR (PRR 85.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valganciclovir2285.185.2
Valganciclovir Hydrochloride2285.185.2
Amphotericin B1479.379.4
Tamsulosin Hydrochloride2174.874.9
Sodium Bicarbonate2269.069.1
Sodium Bicarbonate Injection,2269.069.1
Candesartan Cilexetil2261.061.1
Doxazosin Mesylate2551.051.1
Doxazosin1846.346.3
Darbepoetin Alfa2432.732.7
Minoxidil Foam 5% (Womens)1532.432.4
Minoxidil1523.823.8
Lutetium Lu 177 Vipivotide Tetraxetan315.615.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.